According to the research firm, stem cell market continues to witness massive investments in this research arena. The US has seen some major achievements in the treatment of diseases using stem cell technologies.
The market has shown remarkable growth since 2005 when the first stem cell product entered the market. Presently, the stem cell product sales in the US are mainly through the adult stem cells. The adult stem cells forms the major part of the stem cell product market.
RNCOS claims that adult stem cells have already been proved successful in treating various ailments identified in the report. With more products likely to enter the market in near future mainly in therapeutics areas, the market is expected to earn revenue of $730m by the end of 2012.
The research firm study shows that the prevalence of major chronic diseases and other factors have boosted demand for these products in the market.
Have your say and discuss with your peers on the InfoGrok community.
Participate by posting your comments now.